This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Buttgereit F, Doering G, Schaeffler A, Witte S, Sierakowski S, Gromnica-Ihle E, Jeka S, Krueger K, Szechinski J, Alten R (2008) Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial. Lancet 371:205–214
Dörr HG, Schöfl C (2009) Adrenogenitales Syndrom und Wachstumshormonmangel. Internist 50:1202–1206
Hale GM, Valdes J, Brenner M (2017) The treatment of primary orthostatic hypotension. Ann Pharmacother 51:417–428
Huppertz HI, Pfuller H (1997) Transient suppression of endogenous cortisol production after intraarticular steroid therapy for chronic arthritis in children. J Rheumatol 24:1833–1837
Jüni P, Hari R, Rutjes AW, Fischer R, Silletta MG, Reichenbach S, da Costa BR (2015) Intra-articular corticosteroid for knee osteoarthritis. Cochrane Database Syst Rev 2015:CD5328
Kamada AK, Wiener MB, LaVallee NM, Bartoszek SM, Selner JC, Szefler SJ (1997) A pharmacokinetic comparison of two oral liquid glucocorticoid formulations. Pharmacotherapy 17:353–356
Köbberling J (1979) Gefahren der Depotkortikoid-Therapie. Internist Welt 4:118–122
Mygind N, Laursen LC, Dahl M (2000) Systemic corticosteroid treatment for seasonal allergic rhinitis: a common but poorly documented therapy. Arerugi 55:11–15
Pulzer A, Burger-Stritt S, Hahner S (2016) Morbus Addison, primäre Nebenniereninsuffizienz. Internist 57:457–469
Reinhart WH (2005) Steroidtherapie. Prax (Bern 1994) 94:239–243
Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388:2023–2038
Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JMW, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Poór G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76:960–977
Strehl C, Buttgereit F (2013) Optimized glucocorticoid therapy: teaching old drugs new tricks. Mol Cell Endocrinol 380:32–40
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Der/die Herausgeber bzw. der/die Autor(en), exklusiv lizenziert durch Springer-Verlag GmbH, DE, ein Teil von Springer Nature
About this chapter
Cite this chapter
Schwabe, U. (2020). Corticosteroide. In: Schwabe, U., Ludwig, WD. (eds) Arzneiverordnungs-Report 2020. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-62168-4_22
Download citation
DOI: https://doi.org/10.1007/978-3-662-62168-4_22
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-62167-7
Online ISBN: 978-3-662-62168-4
eBook Packages: Medicine (German Language)